Alliance for Cell Therapy Now
Nonprofit organization working to increase access to safe/effective cell therapies
Based in DC
AI Overview
With $120K in lobbying spend across 8 quarterly filings, Alliance for Cell Therapy Now is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $50K |
| 2022 | $70K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Alliance for Cell Therapy Now disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations
H.R. 941/S. 288, TRANSPLANT Act of 2021; Appropriations for the National Institutes of Health and support for an outcomes database for adult cellular therapies
Funding for regenerative medicine and cell-based therapies
Increased funding for research on regenerative medicine and cell-based therapies at the National Institutes of Health
Increased funding for research on regenerative medicine and cell therapies at the National Institutes of Health; Implementation of the 21st Century Cures Act
Increased funding for research on regenerative medicine and cell-based therapies at the National Institutes of Health; implementation of the 21st Century Cures Act
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.